Informed consent, price transparency, and disclosure

In the American medical system, patients do not know the final price of treatment until long after the treatment is given, at which point it is too late to say “no.” I argue that without price disclosure many, perhaps all, tokens of consent in clinical medicine fall below the standard of valid, info...

Full description

Saved in:  
Bibliographic Details
Main Author: Director, Samuel (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Wiley-Blackwell 2023
In: Bioethics
Year: 2023, Volume: 37, Issue: 8, Pages: 741-747
IxTheo Classification:KBQ North America
NCE Business ethics
NCH Medical ethics
Further subjects:B Informed Consent
B price transparency
B Disclosure
B Cost
B Reasonable Person
Online Access: Presumably Free Access
Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002 4500
001 1860830927
003 DE-627
005 20231010121939.0
007 cr uuu---uuuuu
008 231006s2023 xx |||||o 00| ||eng c
024 7 |a 10.1111/bioe.13206  |2 doi 
035 |a (DE-627)1860830927 
035 |a (DE-599)KXP1860830927 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Director, Samuel  |e VerfasserIn  |4 aut 
245 1 0 |a Informed consent, price transparency, and disclosure 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a In the American medical system, patients do not know the final price of treatment until long after the treatment is given, at which point it is too late to say “no.” I argue that without price disclosure many, perhaps all, tokens of consent in clinical medicine fall below the standard of valid, informed consent. This is a sweeping and broad thesis. The reason for this thesis is surprisingly simple: medical services rarely have prices attached to them that are known to the patient prior to treatment. Yet, for many patients, knowledge of the price is relevant to whether they would give consent. If informed consent requires that patients know all information about their treatment that is relevant to their decision, then consent to a medical intervention in the absence of the price is not informed consent. 
650 4 |a Reasonable Person 
650 4 |a price transparency 
650 4 |a Informed Consent 
650 4 |a Disclosure 
650 4 |a Cost 
652 |a KBQ:NCE:NCH 
773 0 8 |i Enthalten in  |t Bioethics  |d Oxford [u.a.] : Wiley-Blackwell, 1987  |g 37(2023), 8, Seite 741-747  |h Online-Ressource  |w (DE-627)271596708  |w (DE-600)1480658-7  |w (DE-576)078707986  |x 1467-8519  |7 nnns 
773 1 8 |g volume:37  |g year:2023  |g number:8  |g pages:741-747 
856 |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bioe.13206  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via free pdf)] 
856 4 0 |u https://doi.org/10.1111/bioe.13206  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.13206  |x Verlag  |z lizenzpflichtig  |3 Volltext 
912 |a NOMM 
935 |a mteo 
936 u w |d 37  |j 2023  |e 8  |h 741-747 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4381688325 
LOK |0 003 DE-627 
LOK |0 004 1860830927 
LOK |0 005 20231026103502 
LOK |0 008 231006||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2023-09-22#D31CF8750CFD19D4E240EC21FEB9A9831F5FE761 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a zota 
LOK |0 936ln  |0 1442049227  |a KBQ 
LOK |0 936ln  |0 1550736558  |a NCH 
LOK |0 936ln  |0 1442052953  |a NCE 
OAS |a 1 
ORI |a TA-MARC-ixtheoa001.raw